EU/3/16/1744

Table of contents

About

On 14 October 2016, orphan designation (EU/3/16/1744) was granted by the European Commission to BrainRepair UG (haftungsbeschränkt), Germany, for autologous mononuclear cells derived from human cord blood for the treatment of periventricular leukomalacia.

Key facts

Active substance
Autologous mononuclear cells derived from human cord blood
Disease / condition
Treatment of periventricular leukomalacia
Date of decision
14/10/2016
Outcome
Positive
Orphan decision number
EU/3/16/1744

Sponsor's contact details

BrainRepair UG (haftungsbeschränkt)
Universitätsstr. 140
44799 Bochum
Germany
Tel. +49 234 5881 960
Fax +49 234 5881 9619
E-mail: arne.jensen@brainrepair.eu

Patients' organisations

For contact details of patients’ organisations whose activities are targeted at rare diseases, see:

  • Orphanet, a database containing information on rare diseases, which includes a directory of patients’ organisations registered in Europe;
  • European Organisation for Rare Diseases (EURORDIS), a non-governmental alliance of patient organisations and individuals active in the field of rare diseases.

How useful was this page?

Add your rating